FT895
FT895 is a potent and selective HDAC11 inhibitor with an IC50 of 3 nM[1].
Product Specifications
CAS Number
2225728-57-2
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/FT895.html
Concentration
10mM
Purity
99.84
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(NO)C1=C(CN(C2=CN=C(C(F)(F)F)C=N2)C3(C)C)C3=CC=C1
Molecular Formula
C16H15F3N4O2
Molecular Weight
352.31
References & Citations
[1]Martin MW, et al. Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11. Bioorg Med Chem Lett. 2018 Jul 1;28 (12) :2143-2147.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC11
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
IRBAMLPYCARDAP530120UL 120 µL
Rabbit Anti PYCARD Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 50% glycerol, pH7.3) (IHC,Immunofluorescence) 120ul
Sign In for Pricing
View Details 
K1157804 1.0 µg DNA
KLHL20 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details